| | | | | U.S. drugmaker AbbVie Inc said on Friday it would develop an antibody therapy to prevent and treat COVID-19 in partnership with three organizations including the Netherlands' Utrecht University. | | |
| | | China's has registered an outbreak of African swine fever on a small farm in the southwestern Yunnan province, the Ministry of Agriculture and Rural Affairs said on Friday. | | |
| | | An increase in the number of deaths in England and Wales in recent months that have not been linked to COVID-19 could indicate that undiagnosed cases are killing more people than previously thought, data from the Office for National Statistics showed on Friday. | | |
| | | Some countries have seen "upticks" in COVID-19 cases as lockdowns ease, and populations must continue to protect themselves against the coronavirus, the World Health Organization (WHO) said on Friday. | | |
| | | Singapore plans to give a wearable device that will identify people who had interacted with carriers of coronavirus to each of its 5.7 million residents, in what could become one of the most comprehensive contact-tracing efforts globally. | | |
| | | Malaysia reported 19 new confirmed coronavirus cases on Friday, taking the cumulative total to 8,266 infections. | | |
| | | Indonesia reported 703 new coronavirus infections on Friday, taking the number of confirmed cases in the Southeast Asian country to 29,521. | | |
| | | The Philippines' health ministry on Friday confirmed three new coronavirus deaths and 244 more infections, the lowest single-day increase in cases in two weeks. | | |
| | | Thailand is positioning itself as a trusted destination for international tourists after travel restrictions ease, capitalising on its relative success in containing the coronavirus outbreak, industry officials say. | | |
| | | Beijing's municipal government said on Friday it will lower its COVID-19 emergency response from level II to level III effective from Saturday, state media reported. | | |
| | | An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients was retracted on Thursday, adding to controversy around a drug championed by U.S. President Donald Trump. | | |
|
| |
